Sphera Funds Management Ltd. Teva Pharmaceutical Industries LTD Call Options Transaction History

Sphera Funds Management Ltd.

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $1.74 Million - $2.37 Million	136,200 Added 4.35%	3,268,900 $53.1 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $19.7 Million - $26.7 Million	1,848,700 Added 143.98%	3,132,700 $44.2 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $30.3 Million - $39.6 Million	-3,729,800 Reduced 74.39%	1,284,000 $13.4 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $23.4 Million - $33.5 Million	-3,130,900 Reduced 38.44%	5,013,800 $51.1 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $44 Million - $57.8 Million	6,107,700 Added 299.84%	8,144,700 $61.3 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $17 Million - $23.2 Million	2,037,000 New	2,037,000 $18 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $11 Million - $15.5 Million	1,491,600 Added 78.92%	3,381,600 $25.4 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $6.16 Million - $7.89 Million	840,000 Added 80.0%	1,890,000 $17.7 Million
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $7.21 Million - $8.75 Million	-860,000 Reduced 45.03%	1,050,000 $10.2 Million
Q2 2021 Aug 17, 2021	BUY	$9.9 - $11.56 $10.1 Million - $11.8 Million	1,021,200 Added 114.9%	1,910,000 $18.9 Million
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $3.43 Million - $4.25 Million	-331,800 Reduced 27.18%	888,800 $10.3 Million
Q4 2019 Feb 13, 2020	SELL	$6.53 - $10.72 $5.42 Million - $8.89 Million	-829,400 Reduced 40.46%	1,220,600 $12 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $16.6 Million - $32.2 Million	2,050,000 New	2,050,000 $0

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.